EVELOPMENT OF GAS CHROMATOGRAPHY-MASSSPECTROMETRIC (GC-MS) METHOD OF DETERMINATION OF TETRAHYDROCANABINOL AND 11-NORTERAHYDROCANABINOL CARBOXYACIDE IN BIOLOGICAL FLUIDS
PDF

How to Cite

ჯოხაძე მ. J. M., თუშურაშვილი პ. T. P., მურთაზაშვილი თ. M. T., იმნაძე ნ. I. N., & სივსივაძე კ. S. K. (2019). EVELOPMENT OF GAS CHROMATOGRAPHY-MASSSPECTROMETRIC (GC-MS) METHOD OF DETERMINATION OF TETRAHYDROCANABINOL AND 11-NORTERAHYDROCANABINOL CARBOXYACIDE IN BIOLOGICAL FLUIDS. Collection of Scientific Works of Tbilisi State Medical University, 49, 157–159. https://doi.org/10.52340/csw.2015.49.0.157-159

Abstract

In chemichal-toxicological analysis was  used the method  of Gas Chromatography-Mass Spectrometry. It is considered  as one of the most exact method of analysis of chemichal substances. Respectively utilization of this method in determination of widely spread narcotic in biological fluids is important task. As a result of experimental work, was determined optimal conditions of analysis: temperature of injector, fuel and transferline, the thermal gradient, volume of injection, length of the column, thickness of the layer, gass-wearing speed of mobile phase. Detection of Desomorphine was carried by TIC and SIM regime, under the NIST data base. For derivatisation was selected acitilation (acetate anhydride), metilation and sylitation were performed. The optimal sylitation of tetrahydrocanabinol  and 11nor-terahydrocanabinol  carboxyacide was performed by BSTFA. In the current work is presented the chromatograme and mass-specter of tetrahydrocanabinol  and 11-nor-terahydrocanabinol carboxyacide detected in urine.

https://doi.org/10.52340/csw.2015.49.0.157-159
PDF

References

1. C. Clinton Frazee III, Michael Kiscoan, Uttam Garg. Quantitation of Total 11-Nor-9-Carboxy-Delta 9-Tetrahydrocannabinol in Urine and Blood Using Gas ChromatographyMass Spectrometry (GC-MS). Clinical Applications of Mass Spectrometry Volume 603 of the series Methods in Molecular Biology, 2012, pp 137-144
2. Goulle JP, Saussereau E, Lacroix C. Delta-9-tetrahydrocannabinol pharmacoki neti cs. Ann Pharm Fr.2008;66:232–244.
3. Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Herning RI, Cadet JL, et al. Implications of plasma Delta9tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. J Anal Toxicol. 2009;33:469–477
4. Röhrich J, Schimmel I, Zörntlein S, Becker J, Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop. J Anal Toxicol. 2010 May;34(4):196-203.
5. Rebecca Andrews, Sue Paterson. A validated method for the analysis of cannabinoids in post-mortem blood using liquid–liquid extraction and two-dimensional gas chromatography–mass spectrometry. Forensic science internation- al 2012, volum 222, Issues 1-3, Pages 111-117

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...